) [153]. This technique is at present not scalable because it relies on high-priced startup substrates that may be utilised to provide psilocybin in cheaper chemical synthesis methodologies. A methodology for de novo production of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae,Connect with your healthcare service provider When yo